Available Programs

HYPERTENSION
Drawing on the latest information from the Canadian Hypertension Society's 2005 guidelines, CE Essentials: Hypertension presents an overview of the treatment and monitoring of hypertension.
Read the module		Take the test now!

RHEUMATOID ARTHRITIS
Rheumatoid arthritis is a chronic, systemic autoimmune condition primarily affecting joints and surrounding tissue. CE Essentials: Rheumatoid Arthritis reviews this disorder's pathophysiology, signs and symptoms, diagnosis and management. This module also highlights the pharmacist's importance in helping patients understand and manage their disease.
Read the module		Take the test now!

DYSLIPIDEMIA
CE Essentials: Dyslipidemia provides pharmacists with a timely update on the management of dyslipidemia, drawing on recommendations from the 2006 Canadian clinical practice guidelines.
Read the module		Take the test now!

CHRONIC OBSTRUCTIVE PULMONARY DISEASE
CE Essentials: COPD provides a concise yet comprehensive overview of chronic obstructive pulmonary disease, a debilitating condition that is currently the fourth leading cause of death in men and the fifth in women.
Read the module		Take the test now!

SCHIZOPHRENIA
Schizophrenia affects speech, emotions, behaviour and thought. It is often mistakenly confused with multiple personality disorder. CE Essentials: Schizophrenia will help you understand this complex illness, affecting approximately 1% of the world's population.
Read the module		Take the test now!

HEART FAILURE
Drawing on recommendations from the 2006 Canadian guidelines, CE Essentials: Heart Failure provides an overview of heart failure management, with emphasis on the most prominent type, systolic dysfunction heart failure.
Read the module		Take the test now!

TYPE 1 DIABETES
The ‘ins and outs' of insulin dosing are presented in CE Essentials: Type 1 Diabetes. Learn more about the role that pharmacists can play in helping patients (including children and adolescents) manage this challenging lifelong condition.
Read the module		Take the test now!

STROKE
Primary and secondary prevention of ischemic stroke are reviewed in CE Essentials: Stroke, including recommendations for risk factor management. This module also discusses current evidence regarding the use of antiplatelet therapies and warfarin in stroke prevention.
Read the module		Take the test now!

Coming Soon...

Osteoporosis
CE Essentials: Osteoporosis reviews the diagnosis, management and monitoring of this under-recognized condition that affects 1 in 4 women and 1 in 8 men over the age of 50 years.

Osteoarthritis
Osteoarthritis is the most common form of arthritis, affecting an estimated 1 in 10 Canadians. Using the latest clinical practice guidelines, CE Essentials: Osteoarthritis provides pharmacists with an up-to-date summary of its treatment.

Asthma
CE Essential: Asthma gives pharmacists a timely overview of asthma treatment, based on the recently-released Canadian clinical practice guidelines. Highlights include updated asthma control criteria and considerations in pediatric patients.